Use of the continuous glucose monitoring system in the management of hypoglicemia in insulin autoimmune syndrome

Pubblicato online: 11 lug 2022

Pagine: 89 - 92

Ricevuto: 03 gen 2022

Accettato: 31 mag 2022

DOI: https://doi.org/10.2478/amma-2022-0011

Parole chiave

insulin autoimune syndrome, Hirata’s disease, continuous monitoring system, insulin autoantibodies

© 2022 Andrada Raluca Pop et al., published by Sciendo

This work is licensed under the Creative Commons Attribution 4.0 International License.